Testosterone IM Dosage Recommendation
For a free testosterone of 6.0 ng/dL, start with testosterone cypionate or enanthate 100 mg IM weekly, targeting mid-normal total testosterone levels of 500-600 ng/dL. 1
Dosing Algorithm
Initial dosing options (choose based on patient preference and monitoring capability):
- Preferred: 100 mg IM weekly - provides more stable levels and reduces peak-trough fluctuations 1, 2, 3
- Alternative: 50 mg IM weekly - for patients concerned about side effects 2
- Traditional: 100-200 mg every 2 weeks - acceptable but creates more symptom cycling 1, 4
The FDA-approved range is 50-400 mg every 2-4 weeks 4, but modern practice favors weekly dosing because it maintains testosterone in the therapeutic range more consistently and reduces time spent in both supratherapeutic and subtherapeutic ranges 1.
Target Levels and Monitoring
Target total testosterone: 500-600 ng/dL (mid-normal range) 1, 5
Timing of blood draws matters:
- For weekly injections: measure midway between injections (3-4 days after injection) 1
- For every-2-week injections: measure at midpoint (day 7) 5
- Adjust if mid-interval testosterone is >600 ng/dL or <350 ng/dL 6
Monitoring schedule:
- Check testosterone and hematocrit at 3 months after starting 1, 6
- Then annually if stable 5, 6
- PSA and DRE at 3-12 months if age 55-69 or high-risk 6
Critical Safety Considerations
Stop therapy immediately if:
- Hematocrit rises above 54% 5, 6
- PSA increases >1.4 ng/mL in any 12-month period 3, 6
- Confirmed PSA >4.0 ng/mL 6
The 100 mg weekly regimen has a significant safety advantage: Recent research shows men receiving 100 mg weekly had only 1% risk of hematocrit rising above 54%, compared to 8% with 200 mg every 2 weeks 7. This matters for long-term cardiovascular safety, as erythrocytosis is a dose-dependent complication.
Dose Adjustment Strategy
If symptoms persist after 3 months with appropriate testosterone levels:
- First verify compliance and injection technique
- Consider increasing frequency (e.g., 50 mg twice weekly) rather than increasing total dose 8
- Only increase total weekly dose if mid-interval testosterone remains <350 ng/dL 5
Common pitfall: Escalating dose when the issue is actually peak-trough variation. More frequent smaller doses often work better than larger infrequent doses 8.
Formulation Considerations
While the guidelines show testosterone enanthate and cypionate are interchangeable 1, 4, there is some evidence suggesting injections carry higher cardiovascular risk than gels 1. However, this may reflect patient selection bias rather than true formulation differences 1. The practical advantages of injections (cost, no transfer risk, assured compliance) often outweigh theoretical concerns in real-world practice.
For patients who develop problematic peak-trough symptoms despite weekly dosing, consider switching to transdermal gel 5-10 g daily as an alternative 1, 5.